Investec Bank plc has filed a Form 8.5 regulatory disclosure revealing significant trading activity in Advanced Medical Solutions Group plc (AMS.L) ordinary shares.
The disclosure, filed on 11th June 2026, relates to dealings conducted on 10th June 2026 by Investec acting in its capacity as an exempt principal trader.
Investec Bank serves as both Advisor and Joint Broker to Advanced Medical Solutions Group plc, establishing its connected-party status under the Takeover Code.
The trading activity involved the purchase and sale of 112,064 ordinary shares in each direction, representing a balanced client-serving transaction executed on the same date.
On the purchase side, Investec acquired 112,064 ordinary shares at prices ranging from a low of 218 pence to a high of 221 pence per unit.
The corresponding sales of 112,064 ordinary shares were transacted at prices between 219.23 pence and 221 pence per unit, reflecting tight market conditions around the stock.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec confirmed that no cash-settled derivative transactions, stock-settled derivatives, or options were involved in the reported dealings.
The bank also confirmed that no indemnity arrangements, option agreements, or understandings relating to voting rights or future acquisitions were in place in connection with the dealings.
The contact named in the disclosure is Abhishek Gawde, with the filing dated 11th June 2026 in accordance with standard regulatory requirements under the Takeover Code.
Advanced Medical Solutions Group plc (AMS.L) saw its shares move by -1.34% on the day the dealings were conducted, reflecting broader market sentiment around the stock.
Such disclosures are a standard requirement under the Takeover Code, ensuring transparency in trading activity during periods when a company may be subject to offer-related market activity.
